RSS Feeds
Successful Octreotide Treatment of Chylous Pleural Effusion and Lymphedema in the Yellow Nail Syndrome
- Konstantinos Makrilakis, MD, MPH, PhD;
- Spyridon Pavlatos, MD;
- Georgios Giannikopoulos, MD;
- Christos Toubanakis, MD; and
- Nikolaos Katsilambros, MD, PhD
- From University of Athens, Laiko General Hospital, 11527 Athens, Greece.
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
Background: The yellow nail syndrome, a disease of unclear cause, consists of the triad of yellow nails, lymphedema, and respiratory manifestations (bronchiectasis, pleural effusions, recurrent pneumonias, bronchitis, and sinusitis) (1). It results from an abnormality of …
